Search for a command to run...
Combining predictive analytics with machine learning improves the efficacy and efficiency of drug discovery. It takes over a decade of labour to reinstate a new substance into the market with billions of dollars invested. The development of machine learning technologies now allows researchers to conduct rapid analyses of large datasets with a high degree of accuracy. These aspects of machine learning applications to drug design include target identification, lead optimisation, and efficacy prediction. The most significant advantage of machine learning is its ability to sift through a vast array of biological and chemical data in search of potential drug targets, genes, or proteins associated with diseases. Advanced algorithms such as DeepCPI and DeepDTA have been developed to study the biological activity of a compound at an early stage of drug development. This helps focus the exploration of promising candidates. To support the understanding of drug action mechanisms for effective therapeutics, ML analyzes molecular interactions. Among other things, predictive analytics advises patients on potential side effects and drug interactions. A machine learning algorithm, such as eToxPred, uses molecular fingerprints to predict the toxicity of a molecule. Clinical trial data and real-world evidence can be integrated into ML models for the prediction of adverse reactions and thus enable tailoring the dosing regimen at an individual patient level. Similarly, despite the promise, the use of machine learning in drug discovery has slowed. Addressing data quality, algorithm interpretability, and regulatory compliance can maximize their benefit. Ongoing studies refine ML methodologies and work out robust frameworks for use in pharmaceuticals. Continuous development in machine learning techniques will continue to shape the future of drug discovery. This means that as advanced algorithms, such as AlphaFold's structure prediction tool in pharmaceuticals, become established, potential biopharmaceutical innovation will grow exponentially. Consequently, this chapter aims to highlight the importance of adopting such technologies throughout an industry where the average success rates of drug development processes are at an all-time low. The integration of predictive analytics with machine learning facilitates the development of innovative pharmacological solutions.